Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep710 | Pituitary: basic and neuroendocrinology | ECE2015

Patient reported outcomes comparing octreotide capsules to somatostatin analogues injections: results from a multicentre, baseline controlled, phase 3 study in acromegaly

Haviv Asi , Patou Gary , Mathias Susan

Background: Somatostatin analogues are the most widely used medical treatment in acromegaly. The available long-acting formulations are administered parenterally (i.m. or deep s.c. injections). Results of a multicentre, baseline controlled, phase 3 study have recently showed that octreotide capsules are an effective and safe treatment in acromegaly. The Treatment Satisfaction Questionnaire for Medication (TQ15M), assessed in the phase 3 study, as exploratory endpoint, compared...